# Development and validation of a risk prediction model for activities of daily living dysfunction in stroke survivors

## TL;DR

This study developed a model to predict daily living difficulties in stroke survivors, using factors like age and health scores to help improve personalized care.

## Contribution

The novel contribution is a validated risk prediction model for ADL dysfunction in stroke survivors using Chinese population data.

## Key findings

- Six significant predictors of ADL dysfunction were identified, including age and depression scores.
- The model demonstrated good discriminatory power with AUCs of 0.804 and 0.779 in training and testing sets.
- The model showed accurate calibration and clinical utility for personalized medical planning.

## Abstract

Stroke is a leading cause of disability worldwide, imposing a significant burden on patients, families, and society. To create and verify a prediction model for activities of daily living (ADL) dysfunction in stroke survivors, pinpoint key predictors, and analyze the traits of those at risk.

Data from the China Health and Retirement Longitudinal Study wave 5 was used in this cross-sectional study. 1,131 stroke survivors were included and split into training and testing sets. The least absolute shrinkage and selection operator regression and multivariate logistic regression were applied for model development. Model performance was evaluated using the area under the receiver operating characteristic curve(AUC), calibration plots, and decision curve analysis. SHapley Additive exPlanations values were calculated to understand predictor importance.

Six variables (age, the 10-item Center for Epidemiologic Studies Depression Scale score, memory disorder, self-rated health, pain count, and heavy physical activity) were identified as significant predictors. The model showed good discriminatory power (training set AUC = 0.804, testing set AUC = 0.779), accurate calibration, and clinical utility.

A prediction model for ADL dysfunction in stroke survivors was successfully developed and validated. It can help in formulating personalized medical plans, potentially enhancing stroke survivors' ADL ability and quality of life.